Metabical Product: Positioning and Marketing Approach
Executive Summary The case was set to occur in 2008 and entails a product called Metabical, which is an innovative drug prescribed for weight loss, and Cambridge Sciences Pharmaceuticals (CSP) anticipates it to be approved soon. The drug is programmed to be approved by the Food and Drugs Authority (FDA)...